PlainRecalls
FDA Drug Moderate Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

Reported: March 26, 2025 Initiated: March 5, 2025 #D-0277-2025

Product Description

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Details

Units Affected
1223 bottles
Distribution
Nationwide in the USA.
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99. Recalled by Rising Pharma Holding, Inc.. Units affected: 1223 bottles.
Why was this product recalled?
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 26, 2025. Severity: Moderate. Recall number: D-0277-2025.